Form 8-K - Current report:
SEC Accession No. 0001641172-25-005876
Filing Date
2025-04-23
Accepted
2025-04-23 17:00:42
Documents
26
Period of Report
2025-04-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 25261
2 ex99-1.htm EX-99.1 CHARTER 7973
3 ex99-1_001.jpg GRAPHIC 270740
4 ex99-1_002.jpg GRAPHIC 573959
5 ex99-1_003.jpg GRAPHIC 232708
6 ex99-1_004.jpg GRAPHIC 323242
7 ex99-1_005.jpg GRAPHIC 179824
8 ex99-1_006.jpg GRAPHIC 291036
9 ex99-1_007.jpg GRAPHIC 262767
10 ex99-1_008.jpg GRAPHIC 227999
11 ex99-1_009.jpg GRAPHIC 756407
12 ex99-1_010.jpg GRAPHIC 296398
13 ex99-1_011.jpg GRAPHIC 218947
14 ex99-1_012.jpg GRAPHIC 256362
  Complete submission text file 0001641172-25-005876.txt   5564057

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE cocp-20250423.xsd EX-101.SCH 3035
16 XBRL LABEL FILE cocp-20250423_lab.xml EX-101.LAB 34239
17 XBRL PRESENTATION FILE cocp-20250423_pre.xml EX-101.PRE 22372
28 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3538
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38418 | Film No.: 25862310
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)